AI governance committee charter
What it is
The AI governance committee charter is the artifact that satisfies RUAIH focus area 1 — Governance — at the control level.
Who signs it
The chief executive, or the board committee that delegates the authority.
A document without a signature is a draft. An assessor is checking that someone with authority put their name to it.
What an assessor asks for
The charter, the membership roster against it, and minutes for the last three meetings.
What goes in it
- Purpose and scope — which decisions this body owns exclusively
- Membership by seat, not by name: executive leadership, regulatory and ethical compliance, IT, safety and incident reporting, clinical and operational leadership, cybersecurity, and affected stakeholders
- Quorum, and what happens when quorum fails
- The decision-rights matrix — what the committee decides, what it recommends, what it is merely informed of
- Escalation thresholds to the board
- Meeting cadence, and the standing agenda
- How a tool gets on the agenda, and who can put it there
The most common failure
A committee that reviews tools after procurement has a charter and no authority. Write the exclusivity clause first: no AI tool enters production without passing this body. Then check it against how the last three tools actually got in.
Where this sits
See the RUAIH crosswalk for how this control maps across CHAI’s playbooks and the NIST AI RMF.
Written and reviewed by Neel Chauhan, MD MBA, physician-executive and founder of the Healthcare AI Institute. Last reviewed 2026-07-30.
Specified from the published RUAIH focus areas and the September 2025 Joint Commission and CHAI guidance, plus the failure modes we see most often in practice.
The Institute accepts no vendor sponsorship, holds no vendor equity and takes no referral fees.